Tenofovir and Hepatitis B Virus Transmission During Pregnancy
This noninferiority randomized clinical trial investigates whether administering tenofovir to pregnant individuals with hepatitis B virus beginning at gestational week 16 is noninferior to administering tenofovir beginning at gestational week 28 in preventing mother-to-child transmission.
This noninferiority randomized clinical trial investigates whether administering tenofovir to pregnant individuals with hepatitis B virus beginning at gestational week 16 is noninferior to administering tenofovir beginning at gestational week 28 in preventing mother-to-child transmission.
